GH release, IGF-1 responses and endocrine experiments.
What to look for. A measured rise in a hormone is a biological response; check separately for a demonstrated recovery or body-composition outcome.
CJC-1295 is a long-acting growth-hormone-releasing-hormone analog. Human studies measured prolonged GH and IGF-1 responses, which explains interest in the GH axis; the long-acting molecule is distinct from products described as CJC without DAC.
Evidence in this guide: Early randomized endocrine studies in healthy adults.
Read the CJC-1295 guide ↗Ipamorelin is a growth-hormone secretagogue: it stimulates signaling that releases growth hormone. Research examines that endocrine response and how it differs from other growth-hormone-releasing peptides.
Evidence in this guide: Early experimental pharmacology; hormone release and clinical recovery are different outcomes.
Read the Ipamorelin guide ↗The CJC-1295 + Ipamorelin pairing combines two approaches to stimulating growth-hormone release. Research on the individual components drives interest in recovery and body composition; the blend’s ratio and DAC status are essential parts of its identity.
Evidence in this guide: Separate CJC-1295 human studies and ipamorelin pharmacology; these are not a clinical trial of the combined vial.
Read the CJC-1295 + Ipamorelin guide ↗Sermorelin corresponds to the active 1–29 fragment of growth-hormone-releasing hormone. It signals the pituitary to release growth hormone, making the GH response the central subject of the human physiology research linked here.
Evidence in this guide: Human endocrine experiments; clinical goals and formulations need their own documentation.
Read the Sermorelin guide ↗Hexarelin is a growth-hormone-releasing peptide. The linked experimental work examines how GHRH and somatostatin, two regulators of growth-hormone secretion, contribute to its effects.
Evidence in this guide: Preclinical endocrine mechanism studies.
Read the Hexarelin guide ↗GHRP-2, or pralmorelin, stimulates growth-hormone release. The supervised human study linked here tested its role in evaluating adult growth-hormone deficiency.
Evidence in this guide: Human diagnostic endocrine research, distinct from a recovery or wellness protocol.
Read the GHRP-2 guide ↗GHRP-6 is a growth-hormone-releasing hexapeptide. Researchers compare its signaling with growth-hormone-releasing hormone to understand how pituitary cells release GH.
Evidence in this guide: Rat pituitary-cell experiments in the selected original paper.
Read the GHRP-6 guide ↗